(Wired)
Impossible Foods pulled its notice and resubmitted with additional safety studies done on rats. And on Monday, in a win for the faux meat startup, the FDA came back with no further questions. “Based on the information that Impossible Foods provided, as well as other information available to FDA,” the agency wrote in a letter to the startup, “we have no questions at this time regarding Impossible Foods’ conclusion that soy leghemoglobin preparation is GRAS under its intended conditions of use to optimize flavor in ground beef analogue products intended to be cooked.” Meaning, the FDA needs no further clarifications on Impossible Foods’ arguments that consuming soy leghemoglobin in the Impossible Burger will not have adverse impacts on human health.